TLSI: Innovative tumor therapy delivery, rapid growth, and new product launches drive future outlook
The company is driving innovation in solid tumor therapy with a unique catheter technology, expanding its sales force, and targeting new clinical indications. Strong revenue growth, improving margins, and a robust cash position support its outlook, with key catalysts including new product launches…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.